Reckitt Benckiser Group plc (LON:RKT – Get Free Report)’s share price rose 0.5% during mid-day trading on Thursday . The company traded as high as GBX 4,890 ($60.75) and last traded at GBX 4,858.61 ($60.36). Approximately 469,236 shares changed hands during mid-day trading, a decline of 84% from the average daily volume of 3,023,673 shares. The stock had previously closed at GBX 4,833 ($60.04).
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reduced their price target on Reckitt Benckiser Group from GBX 5,200 ($64.60) to GBX 5,177 ($64.31) and set a “hold” rating for the company in a research report on Wednesday, October 23rd.
Get Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Up 0.2 %
Insider Buying and Selling
In related news, insider Shannon Eisenhardt sold 1,368 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The stock was sold at an average price of GBX 4,723 ($58.67), for a total value of £64,610.64 ($80,261.66). Also, insider Fiona Dawson acquired 25 shares of the stock in a transaction on Wednesday, October 23rd. The shares were bought at an average price of GBX 4,923 ($61.16) per share, for a total transaction of £1,230.75 ($1,528.88). 0.05% of the stock is owned by insiders.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- 3 Warren Buffett Stocks to Buy Now
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Nebius Group: The Rising Star in AI Infrastructure
- Technology Stocks Explained: Here’s What to Know About Tech
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.